MétaCan
Menu
← Back to cohort
Record W4415452218 · doi:10.1210/jendso/bvaf149.2257

SAT-339 Predictors and Prognostic Significance of Post-operative Anti-thyroglobulin Antibody Positivity in Patients With Differentiated Thyroid Cancer: A Retrospective Cohort Study

2025· article· en· W4415452218 on OpenAlexaff
Matthew D. Leeder, Andrew T. Day, Josh Lakoff

Bibliographic record

VenueJournal of the Endocrine Society · 2025
Typearticle
Languageen
FieldMedicine
TopicThyroid Cancer Diagnosis and Treatment
Canadian institutionsUniversity of TorontoQueen's University
Fundersnot available
KeywordsThyroid cancerRetrospective cohort studyThyroidectomyThyroglobulinThyroiditisThyroidProportional hazards modelAnti-thyroid autoantibodiesCohort study

Abstract

fetched live from OpenAlex

Abstract Disclosure: M. Leeder: None. A. Krishnan: None. A. Day: None. S.F. Awad: None. J.M. Lakoff: None. Background: Serum thyroglobulin (Tg) is a key prognostic marker in differentiated thyroid cancer (DTC). Twenty-five percent of DTC patients have positive serum anti-thyroglobulin antibodies (TgAb), which directly interfere with Tg measurement, thus impacting prognostication. Growing evidence suggests that TgAb-positivity is associated with an increased risk of persistent/recurrent disease (PRD). Little is known about what risk factors are associated with TgAb-positivity in DTC patients. Methods: We retrospectively studied 329 DTC patients aged ≥18 who underwent total thyroidectomy and had at least one documented TgAb on follow-up seen at Kingston Health Sciences Centre between January 1, 2000, and September 1, 2023. Using a proportional hazards model, we examined the association between nine potential risk factors and TgAb-positivity. Using the Cox model for time-dependent covariates, we examined the association between “current” TgAb status and risk of PRD. We investigated TgAb status alone and in combination with Tg status. Results: Of 329 DTC patients aged ≥ 18 who underwent total thyroidectomy with documented TgAb on follow-up, 38.9% had at least one positive TgAb. Lymphocytic thyroiditis (LT) was the strongest predictor of TgAb-positivity (HR=2.28, 95% CI 1.55-3.33, p<0.0001). Other associated risk factors were stage > 1 (p=0.009), family history of thyroid cancer (HR = 2.27, 95% CI, 1.02-5.05, p=0.044), and age at diagnosis (HR = 0.98, 95% CI 0.97-1.00, p = 0.028). TgAb-positivity was associated with increased PRD risk (HR=2.8, 95% CI, 1.5-5.3, p=0.0015). Combined positive TgAb and detectable Tg were associated with increased PRD risk compared to combined TgAb-negativity and undetectable Tg (HR = 29.6, 95% CI, 6.3-138.1). LT was associated with decreased PRD risk (HR = 0.39, 95% CI, 0.17 to 0.92, p=0.031). Conclusions: Longer follow-up periods and high-sensitivity assays may account for an increased prevalence of TgAb-positivity among DTC patients. LT was the most significant predictor of TgAb-positivity. Higher cancer stage, family history of thyroid cancer, and younger age at diagnosis were also associated with TgAb-positivity. TgAb-positivity is associated with increased PRD risk. This risk may be higher in patients with combined positive TgAb and detectable Tg. While LT is associated with TgAb-positivity, these patients have a lower risk of PRD. Presentation: Saturday, July 12, 2025

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.267
Teacher spread0.263 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Endocrine Society→Same topicThyroid Cancer Diagnosis and Treatment→French-language works237,207→